Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Sep 30, 2016 | $180B |
| FY2017, ended Sep 30, 2017 | $222B |
| FY2018, ended Sep 30, 2018 | $308B |
| FY2019, ended Sep 30, 2019 | $344B |
| FY2020, ended Sep 30, 2020 | $396B |
| FY2021, ended Sep 30, 2021 | $436B |
| FY2022, ended Sep 30, 2022 | $340B |
| FY2023, ended Sep 30, 2023 | $429B |
| FY2024, ended Sep 30, 2024 | $520B |
| FY2025, ended Sep 30, 2025 | $631B |
| Trailing 12 months to Mar 31, 2026 (through Q2 FY2026) | $550B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Sep 30, 2016 | $15.1B |
| FY2017, ended Sep 30, 2017 | $18.4B |
| FY2018, ended Sep 30, 2018 | $20.6B |
| FY2019, ended Sep 30, 2019 | $23.0B |
| FY2020, ended Sep 30, 2020 | $21.8B |
| FY2021, ended Sep 30, 2021 | $24.1B |
| FY2022, ended Sep 30, 2022 | $29.3B |
| FY2023, ended Sep 30, 2023 | $32.7B |
| FY2024, ended Sep 30, 2024 | $35.9B |
| FY2025, ended Sep 30, 2025 | $40.0B |
| Trailing 12 months to Mar 31, 2026 (through Q2 FY2026) | $43.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Sep 30, 2016 | $5.99B | $5.05B |
| FY2017, ended Sep 30, 2017 | $6.70B | $8.61B |
| FY2018, ended Sep 30, 2018 | $10.3B | $12.2B |
| FY2019, ended Sep 30, 2019 | $12.1B | $12.0B |
| FY2020, ended Sep 30, 2020 | $10.9B | $9.70B |
| FY2021, ended Sep 30, 2021 | $12.3B | $14.5B |
| FY2022, ended Sep 30, 2022 | $15.0B | $17.9B |
| FY2023, ended Sep 30, 2023 | $17.3B | $19.7B |
| FY2024, ended Sep 30, 2024 | $19.7B | $18.7B |
| FY2025, ended Sep 30, 2025 | $20.1B | $21.6B |
| Trailing 12 months to Mar 31, 2026 (through Q2 FY2026) | $22.2B | $21.2B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Sep 30, 2016 | $5.62B |
| FY2017, ended Sep 30, 2017 | $9.87B |
| FY2018, ended Sep 30, 2018 | $8.16B |
| FY2019, ended Sep 30, 2019 | $7.84B |
| FY2020, ended Sep 30, 2020 | $16.3B |
| FY2021, ended Sep 30, 2021 | $16.5B |
| FY2022, ended Sep 30, 2022 | $15.7B |
| FY2023, ended Sep 30, 2023 | $16.3B |
| FY2024, ended Sep 30, 2024 | $12.0B |
| FY2025, ended Sep 30, 2025 | $17.2B |
| Trailing 12 months to Mar 31, 2026 (through Q2 FY2026) | $12.4B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Sep 30, 2016 | $15.9B |
| FY2017, ended Sep 30, 2017 | $16.6B |
| FY2018, ended Sep 30, 2018 | $16.6B |
| FY2019, ended Sep 30, 2019 | $16.7B |
| FY2020, ended Sep 30, 2020 | $24.1B |
| FY2021, ended Sep 30, 2021 | $21.0B |
| FY2022, ended Sep 30, 2022 | $22.4B |
| FY2023, ended Sep 30, 2023 | $20.5B |
| FY2024, ended Sep 30, 2024 | $20.8B |
| FY2025, ended Sep 30, 2025 | $25.2B |
| Trailing 12 months to Mar 31, 2026 (through Q2 FY2026) | $24.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 16.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Sep 30, 2016 | 2.18B |
| FY2017, ended Sep 30, 2017 | 2.11B |
| FY2018, ended Sep 30, 2018 | 2.05B |
| FY2019, ended Sep 30, 2019 | 2.00B |
| FY2020, ended Sep 30, 2020 | 1.98B |
| FY2021, ended Sep 30, 2021 | 1.96B |
| FY2022, ended Sep 30, 2022 | 1.91B |
| FY2023, ended Sep 30, 2023 | 1.86B |
| FY2024, ended Sep 30, 2024 | 1.89B |
| FY2025, ended Sep 30, 2025 | 1.85B |
| Trailing 12 months to Mar 31, 2026 (through Q2 FY2026) | 1.82B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Sep 30, 2016 | — | $221M | $5.72B |
| FY2017, ended Sep 30, 2017 | $6.89B | $235M | — |
| FY2018, ended Sep 30, 2018 | $7.19B | $327M | — |
| FY2019, ended Sep 30, 2019 | $8.61B | $407M | — |
| FY2020, ended Sep 30, 2020 | $8.11B | $416M | — |
| FY2021, ended Sep 30, 2021 | $8.68B | $542M | — |
| FY2022, ended Sep 30, 2022 | $11.6B | $602M | — |
| FY2023, ended Sep 30, 2023 | $12.1B | $765M | — |
| FY2024, ended Sep 30, 2024 | $16.7B | $850M | — |
| FY2025, ended Sep 30, 2025 | $18.3B | $897M | — |
| Trailing 12 months to Mar 31, 2026 (through Q2 FY2026) | $21.3B | $920M | — |
Valuation
At current price- Market Cap
- $732B
- P/E
- 32.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 17.0×
- Price / Book
- 20.5×
- EV / EBITDA
- 26.9×
Growth
Trailing 12 months- Revenue (TTM)
- $43.0B
- Revenue Growth YoY
- 14.4%
- Revenue CAGR 3Y
- 10.9%
- Revenue CAGR 5Y
- 12.9%
- EPS Growth YoY
- —. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- 11.8%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 61.1%
- Net Margin
- 51.7%
- FCF Margin
- 49.2%
- Return on Equity
- 60.3%
Earnings
Trailing 12 months- Net Income
- $22.2B
- EPS (diluted)
- —
- EBITDA
- $27.6B
- Operating Income
- $26.3B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $12.4B
- Total Debt
- $24.0B
- Net Debt
- $11.6B
- Total Assets
- $95.0B
- Total Liabilities
- $59.4B
- Shareholders' Equity
- $35.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $22.8B
- Capital Expenditure
- $1.57B
- Free Cash Flow
- $21.2B
Dividends and risk
Last 12 months- Dividend Yield
- 0.7%
- Dividend / Share
- $2.68
- Beta (5Y)
- 0.77
Every ratio is calculated from the company’s reported figures.